Inmune Bio Inc (INMB)

May 18, 2025

Where are the Opportunities in (INMB) - news.stocktradersdaily.com

May 18, 2025

May 18, 2025

Dimensional Fund Advisors LP Acquires 10,491 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 18, 2025

May 15, 2025

INmune Bio: XPro Trial Readout In Alzheimer’s Disease Offers Big Opportunity (NASDAQ:INMB) - Seeking Alpha

May 15, 2025

May 15, 2025

Wells Fargo & Company MN Buys 2,155 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 15, 2025

May 14, 2025

INmune Bio to Attend RBC Healthcare Conference - TipRanks

May 14, 2025

May 14, 2025

INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 14, 2025

May 14, 2025

INmune Bio Sets Stage for Key Biotech Insights at RBC Healthcare Conference Next Week - Stock Titan

May 14, 2025

May 14, 2025

Raymond James raises INmune Bio stock target to $23 - MSN

May 14, 2025

May 14, 2025

Barclays PLC Increases Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 14, 2025

May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025

May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 12, 2025

INmune Bio’s Earnings Call: Promise and Challenges - TipRanks

May 12, 2025

May 10, 2025

Mariner LLC Acquires New Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 10, 2025

May 09, 2025

Earnings call transcript: INmune Bio Q1 2025 shows narrowed losses, stock rises - Investing.com

May 09, 2025

May 09, 2025

INmune Bio Reports Q1 2025 Results and Updates - TipRanks

May 09, 2025

May 08, 2025

INMUNE BIO Earnings Results: $INMB Reports Quarterly Earnings - Nasdaq

May 08, 2025

May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - The Manila Times

May 08, 2025

May 08, 2025

(INMB) Trading Signals - news.stocktradersdaily.com

May 08, 2025

May 08, 2025

INmune Bio appoints new accounting firm By Investing.com - Investing.com Nigeria

May 08, 2025

May 07, 2025

INmune Bio appoints new accounting firm - Investing.com

May 07, 2025

May 07, 2025

INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

May 07, 2025

May 07, 2025

JPMorgan Chase & Co. Has $53,000 Stock Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 07, 2025

May 05, 2025

INmune Bio Inc expected to post a loss of 47 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025

May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on ... - Eagle-Tribune

May 05, 2025

May 02, 2025

Renaissance Technologies LLC Increases Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 02, 2025

May 02, 2025

LPL Financial LLC Boosts Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 02, 2025

May 02, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average PT from Analysts - Defense World

May 02, 2025

May 01, 2025

INmune Bio (INMB) Expected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Geode Capital Management LLC Has $1.70 Million Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Apr 30, 2025

Apr 23, 2025

A stock that deserves closer examination: INmune Bio Inc (INMB) - uspostnews.com

Apr 23, 2025

Apr 23, 2025

(INMB) Technical Data - news.stocktradersdaily.com

Apr 23, 2025

Apr 16, 2025

Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™ - TipRanks

Apr 16, 2025

Apr 16, 2025

INmune Bio secures key patent opinion for CORDStrom platform By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

INmune Bio Receives Favorable Opinion from USPTO on CORDStrom Patent Application - marketscreener.com

Apr 16, 2025

Apr 16, 2025

INmune Bio Inc. Achieves Key Patent Milestone for CORDStrom™ Cell Therapy Platform - Nasdaq

Apr 16, 2025

Apr 16, 2025

INmune Bio secures key patent opinion for CORDStrom platform - Investing.com

Apr 16, 2025

Apr 16, 2025

Patent Win: INmune Bio's Revolutionary Cell Therapy Secures 20+ Years Protection - Stock Titan

Apr 16, 2025

Apr 15, 2025

INmune Bio (INMB) Partners with CGT Catapult for Large-Scale Cel - GuruFocus

Apr 15, 2025

Apr 14, 2025

INmune Bio Partners with Cell and Gene Therapy Catapult - MSN

Apr 14, 2025

Apr 14, 2025

INmune Bio (INMB) Partners to Enhance Cell Therapy Production - GuruFocus

Apr 14, 2025

Apr 14, 2025

INmune Bio in pact with Cell and Gene Therapy Catapult (INMB) - Seeking Alpha

Apr 14, 2025

Apr 14, 2025

INmune Bio, CGT Catapult Partner To Scale CORDStrom Manufacturing For Commercial Launch - Nasdaq

Apr 14, 2025

Apr 14, 2025

INmune Bio Collaborating With Cell and Gene Therapy Catapult to Scale Manufacturing - MarketScreener

Apr 14, 2025

Apr 14, 2025

INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness - The Manila Times

Apr 14, 2025

Apr 14, 2025

INmune Bio's Game-Changing Partnership Accelerates CORDStrom Production for 4,000 RDEB Patients - Stock Titan

Apr 14, 2025

Apr 09, 2025

Inmune Bio Presents Alzheimer’s Trial Data at Conference - TipRanks

Apr 09, 2025

Apr 07, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average Price Target from Brokerages - Defense World

Apr 07, 2025

Apr 06, 2025

Trend Tracker for (INMB) - news.stocktradersdaily.com

Apr 06, 2025

Apr 04, 2025

INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update - ADVFN

Apr 04, 2025

Apr 01, 2025

INmune Bio Presents MINDFuL Trial Data At AD/PD 2025 - Nasdaq

Apr 01, 2025

Apr 01, 2025

INmune Bio Presents Baseline Data From MINDFuL Phase II Trial In Early Alzheimer's Disease - Nasdaq

Apr 01, 2025

Apr 01, 2025

INmune Bio presents early Alzheimer’s trial data at AD/PD - Investing.com

Apr 01, 2025